PT81004B - Processo para a preparacao de oxindoles trigiclicos uteis como agentes anti-inflamatorios - Google Patents

Processo para a preparacao de oxindoles trigiclicos uteis como agentes anti-inflamatorios

Info

Publication number
PT81004B
PT81004B PT81004A PT8100485A PT81004B PT 81004 B PT81004 B PT 81004B PT 81004 A PT81004 A PT 81004A PT 8100485 A PT8100485 A PT 8100485A PT 81004 B PT81004 B PT 81004B
Authority
PT
Portugal
Prior art keywords
sub
trigiclic
oxindols
preparation
inflammatory agents
Prior art date
Application number
PT81004A
Other languages
English (en)
Other versions
PT81004A (en
Inventor
Lawrence Sherman Melvin Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT81004A publication Critical patent/PT81004A/pt
Publication of PT81004B publication Critical patent/PT81004B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
PT81004A 1984-08-24 1985-08-22 Processo para a preparacao de oxindoles trigiclicos uteis como agentes anti-inflamatorios PT81004B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1984/001371 WO1986001510A1 (en) 1984-08-24 1984-08-24 Tricyclic oxindole antiinflammatory agents

Publications (2)

Publication Number Publication Date
PT81004A PT81004A (en) 1985-09-01
PT81004B true PT81004B (pt) 1987-12-30

Family

ID=22182243

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81004A PT81004B (pt) 1984-08-24 1985-08-22 Processo para a preparacao de oxindoles trigiclicos uteis como agentes anti-inflamatorios

Country Status (21)

Country Link
US (1) US4695571A (pt)
EP (1) EP0173520B1 (pt)
JP (1) JPS6157554A (pt)
KR (1) KR870001144B1 (pt)
AT (1) ATE49211T1 (pt)
AU (1) AU553859B2 (pt)
CA (1) CA1244427A (pt)
DE (1) DE3575140D1 (pt)
DK (1) DK160098C (pt)
EG (1) EG17287A (pt)
ES (2) ES8704497A1 (pt)
FI (1) FI79319C (pt)
GR (1) GR852026B (pt)
HU (2) HU203238B (pt)
IE (1) IE58739B1 (pt)
IL (1) IL76175A (pt)
PH (1) PH23065A (pt)
PL (2) PL147395B1 (pt)
PT (1) PT81004B (pt)
WO (1) WO1986001510A1 (pt)
ZA (1) ZA856403B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS63223492A (ja) * 1987-03-11 1988-09-16 Okawara Mfg Co Ltd 熱交換器
WO1990008146A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
WO1990008145A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
US5047554A (en) 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5300655A (en) * 1989-04-18 1994-04-05 Pfizer Inc. 2-carboxy-thiophene derivatives
JPH04217684A (ja) * 1990-05-30 1992-08-07 Shionogi & Co Ltd アルド−ス還元酵素阻害物質
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US4644005A (en) * 1984-10-31 1987-02-17 Pfizer Inc. Oxindole antiinflammatory agents

Also Published As

Publication number Publication date
ZA856403B (en) 1987-04-29
AU4663785A (en) 1986-02-27
GR852026B (pt) 1985-12-19
IE852081L (en) 1986-02-24
ES552044A0 (es) 1987-06-01
AU553859B2 (en) 1986-07-31
PL147395B1 (en) 1989-05-31
DE3575140D1 (de) 1990-02-08
EG17287A (en) 1993-02-28
EP0173520A3 (en) 1986-05-14
HUT47580A (en) 1989-03-28
ES8704497A1 (es) 1987-04-01
DK382685A (da) 1986-02-25
PH23065A (en) 1989-03-27
DK160098C (da) 1991-06-24
FI79319C (fi) 1989-12-11
FI79319B (fi) 1989-08-31
HU902020D0 (en) 1990-07-28
JPH0450316B2 (pt) 1992-08-13
KR870002143A (ko) 1987-03-30
WO1986001510A1 (en) 1986-03-13
IL76175A (en) 1989-08-15
DK160098B (da) 1991-01-28
FI861704A0 (fi) 1986-04-23
US4695571A (en) 1987-09-22
PL147393B1 (en) 1989-05-31
PT81004A (en) 1985-09-01
KR870001144B1 (ko) 1987-06-11
EP0173520A2 (en) 1986-03-05
ES8706116A1 (es) 1987-06-01
HU203238B (en) 1991-06-28
IE58739B1 (en) 1993-11-03
JPS6157554A (ja) 1986-03-24
HU203350B (en) 1991-07-29
ES546377A0 (es) 1987-04-01
IL76175A0 (en) 1985-12-31
FI861704A (fi) 1986-04-23
ATE49211T1 (de) 1990-01-15
PL255089A1 (en) 1986-12-30
CA1244427A (en) 1988-11-08
EP0173520B1 (en) 1990-01-03
DK382685D0 (da) 1985-08-23

Similar Documents

Publication Publication Date Title
PT81004B (pt) Processo para a preparacao de oxindoles trigiclicos uteis como agentes anti-inflamatorios
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
KR860004882A (ko) 항 알레르기제로서 유용한 신규의 산성 인돌화합물 및 그 제조방법
ES525122A0 (es) Procedimiento para preparar derivados de piridina
HUT37398A (en) Process for preparing 3-substituted-2-oxindole-1-carboxamide derivatives with analgetic and antiinflammatory activity
ES2062143T3 (es) Derivados de pirrol sustituidos con grupos acriloilo y procedimiento para su preparacion.
AU546057B2 (en) Dihydropyridine derivatives
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
ATE30019T1 (de) Bicyclooxyarylthioharnstoffe und herstellungsverfahren.
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE140229T1 (de) Benzoxazepinon-verfahren
ATE40554T1 (de) Furo(3,2-c>pyridinderivate, ihre herstellung und ihre therapeutische verwendung.
PT92494A (pt) Processo para a preparacao de novos derivados do indol
ATE79625T1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indol-1-essigs|uren.
ATE56440T1 (de) 6-oxo-pyridazinyl-verbindungen.
ES557083A0 (es) Un metodo para preparar pirrolo (1,2-b) (1,2,5) triazepinas

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20001231